Disease Learning

You are here

Disease Learning

If you have been NEWLY DIAGNOSED  START HERE 

Disease Learning

Video Library

Lung Cancer Video Library - What Should Patients With Rapid Progression Through 1st Line Treatment Receive Next?
Dr. H. Jack West, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, President and CEO of GRACE offers updates to our Lung Cancer...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer
Lung Cancer Video Library - "Consolidation" Radiation After a Good Response to First Line Therapy - Who and Why
Dr. H. Jack West, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, President and CEO of GRACE offers updates to our Lung Cancer...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer
Lung Cancer Video Library - Chemotherapy and Immunotherapy Combinations in Advanced Non-Squamous NSCLC
Dr. H. Jack West, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, President and CEO of GRACE offers updates to our Lung Cancer...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Non Small Cell Lung Cancer, Chemotherapy, Immunotherapies
ASCO 2018 Roundtable - Lung Cancer - Potential Showdown of Two Positive Trials? Keynote 407 and IMPower 131
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Chemo Medication, Immunotherapies, Chemotherapy
ASCO 2018 Roundtable - Lung Cancer - Keynote189 - Cisplatin or Carboplatin with Alimta & Keytruda - Is this a Practice Changing Approach?
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Chemo Medication, Immunotherapies, Chemotherapy

Articles

Retrospective Data and Real World Evidence: The Poor Stepchild of Clinical Trials?
Many physicians worship evidence-based medicine, which is generally a very good practice that ensures that medical practice isn’t dictated by our...
Cancer Journey:
Cancer Type:
Lung Cancer, Blood Cancers, Head and Neck Cancer, Other
Disease Learning:
Clinical Trials
My Top 10 ASCO 2017 Lung Cancer Presentations
Over the next few days, about 30,000 oncologists and other cancer care professionals, along with a growing number of patient advocates, are...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Non Small Cell Lung Cancer, Small Cell Lung Cancer
New FDA Approval for Zykadia (ceritinib) for ALK-Positive NSCLC: Why I Think It's a Poor Choice for Initial Treatment
The FDA just approved a new therapy for the approximately 4% of patients with NSCLC who have the molecular marker known as an ALK rearrangement. The...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy, Targeted Therapies – ALK
Targeted Therapies Patient Forum September 2017 Speaker Highlight - James Stevenson, MD
GRACE is excited to continue to build the faculty and agenda for the upcoming Targeted Therapies Patient Forum, September 16, 2017. See more information about our presenters in Speaker Highlights - today we introduce James Stevenson, MD.
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy
Translation of Molecular Genetics in Lung Cancer into Treatment Decision
Christine M. Walko, Pharm.D., discusses how advancements in technology have improved the quality, cost and turnaround time for assessing genetic mutations in tumor tissue, and how this has helped to translate precision medicine into standard clinical practice.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Molecular Testing, General Lung Cancer

Community Forum

Stage IIIb ALK NSCLC first line treatment
This question is not for a specific patient, it is designed to understand how oncologists would approach this problem. There’s a 50 year old stage...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapies – ALK, Non Small Cell Lung Cancer
Tough decision between a whole brain radiation vs occipital craniotomy
My wife is experiencing a second time brain tumor recurrence. She had her first occipital craniotomy back in 2011. On late Oct 2013 she began to...
Cancer Journey:
In Treatment, Survivorship
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, General Lung Cancer, Symptoms, Pain Medication, Procedures & Treatments, Maintenance Therapy, Radiation Therapy, Non Small Cell Lung Cancer
Alternative medicine
My father has been dealing with prostate cancer for a couple of years now and is about to begin treatment. Does anybody have any information or...
Cancer Journey:
Cancer Type:
Disease Learning:
Chemotherapy
Vaxira for stage 4 NSCLC
Has anyone any information on obtaining and using Vaxira, the Cuban drug, for stage 4 advanced NSCLC? Not sure if US citizens can still travel to...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
ANGIOGENESIS, 3rd Line and beyond, Targeted Therapy, Investigational Agents, Non Small Cell Lung Cancer
Can Tagrisso be used in additional to Alimta maintenance
My wife was on Tarceva for over 6 1/2 years. Then she developed acquired resistance to Tarceva with prevascular and supraclevical lymph nodes...
Cancer Journey:
Survivorship
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapies - EGFR, Biopsy/Tissue Collection, Maintenance Therapy, Non Small Cell Lung Cancer